FA ALPHA

FA Alpha

Help your clients meet their goals with unique monthly equity and macro insights.

Unique Uniform Accounting tools built for Financial Advisors

FA Alpha Pulse

FA Alpha 50

Latest FA Alpha 50:

Regeneron Pharmaceuticals (REGN) - A drug development platform poised for further success

The market thinks this biotech giants heyday is coming to an end, but the firm has another blockbuster ready to take the reins and a strong pipeline and investment firepower signals more growth can come.

See the full UAFRS toolbox.

Contact our customer satisfaction representatives to learn about all of the tools Valens offers. Talk to us today to see how our subscription packages could be a perfect addition to your investment process.

Please leave us your contact details so we can reach out to you as soon as we can.

Interested in getting unique Uniform Accounting insights right to your inbox every day?

No credit card required, our FA Alpha Daily newsletter is free of charge.
And loaded with things you won’t hear anywhere else.

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683